Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro

Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro

A limited number of effective therapies are currently available to treat human coronavirus SARS-CoV-2 and other human coronaviruses, which are responsible for nearly a third of global cases of the common cold. The possibility of new emerging coronaviruses demands powerful new antiviral strategies. L...

Full description

Bibliographic Details
Main Authors: Sabina Andreu, Inés Ripa, Raquel Bello-Morales, José Antonio López-Guerrero
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Viruses
Subjects:
lactoferrin
liposomal lactoferrin
antivirals
SARS-CoV-2
COVID-19
Online Access:https://www.mdpi.com/1999-4915/15/4/972

Internet

https://www.mdpi.com/1999-4915/15/4/972

Similar Items